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 A Multifuntional Nanoplatform Based on Responsive 
Fluorescent Plasmonic ZnO-Au@PEG Hybrid Nanogels  Under a rational design, combining multiple constituents into a single nano-
object will not only bridge the unique properties of individual materials to 
leverage research both fundamentally and practically, but will also improve 
conventional sensing, imaging, and therapeutic effi cacies. Such a nano-
object ( < 100 nm) can be constructed by covalently bonding ZnO quantum 
dots (QDs) to nonlinear poly(ethylene glycol)-based nanogel network chains, 
followed by appropriate growth of metallic Au. With the polymer gel network 
serving as a three-dimensional scaffold, the fl uorescence of ZnO QDs can 
be well protected, while metal Au still retains its surface plasmon reso-
nance property. The ZnO QDs covalently bonded to the thermo-responsive 
gel network chains can sensitively respond to temperature change of the 
surrounding fl uids over the physiologically important range of 37–42  ° C, 
converting the disruptions in homeostasis of local temperature into stable, 
robust and high-resolution fl uorescent signals. The thermoresponsive 
hybrid nanogels can not only enter into and light up B16F10 cells, but also 
regulate the release of a model anticancer drug, temozolomide, in response 
to either local environmental temperature change or external near-infrared 
light-induced localized hyperthermia from metal Au. The combined chemo-
photothermal therapy can signifi cantly improve the therapeutic effi cacy due 
to a synergistic effect.  1. Introduction 
 The ability of a single object to perform multiple functions is 
often cited as an advantageous characteristic of nanoplatforms 
that cannot be achieved with the individual constituents. Spe-
cifi c integration of different building blocks with desired optical, 
electronic, and collective properties into a single structure has 
resulted in novel platforms of materials that may lead the way 
to various future technologies, such as chemical and biochem-
ical sensing, [ 1 ] multimodal imaging, [ 2 ] and simultaneous dia-
gnosis and therapy. [ 3 ] Fluorescence is by far the most powerful © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinhewileyonlinelibrary.com
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because it can be noninvasive and work-
able in even strong electromagnetic fi elds. 
Among various kinds of materials, semi-
conductor quantum dots (QDs) as fl uo-
rescent probes have attracted increasing 
interest due to their high quantum yield, 
photostability, and wideband excitation. [ 4 ] 
Recently, fl uorescent hybrid nanogels, 
which are capable of transducing volume 
phase transitions into a change in fl uo-
rescence intensity, have been constructed 
by the physical incorporation of QDs into 
stimuli-responsive polymer networks by 
our group [ 5 ] and others. [ 6 ] On the other 
hand, Au nanoparticles (NPs) constitute 
another major class of nanomaterials. 
Metallic Au has promising therapeutic 
properties as a hyperthermal agent due 
to its effi cient photo-to-heat conversion 
ability, which can induce a local tempera-
ture increase around Au NPs under light 
illumination through the tunable sur-
face plasmon resonance (SPR) bands in 
the near-infrared (NIR) region. [ 7 ] Au NPs 
have also been used for NIR-controlled 
release of anticancer drugs. Covered with temperature-responsive polymers, the Au NPs can convert the 
NIR light to heat that can induce the responsive polymers to 
collapse, which further trigger the release of the pre-loaded 
drugs. [ 3 b, 8,9 ] Fluorescent temperature sensing is necessary in 
hyperthermal and photodynamic cancer therapies because 
knowing the temperature of Au-based drug carriers and patho-
logical tissue is essential in order to achieve optimal therapeutic 
results. Moreover, pathological cells are warmer than normal 
cells by 1–5  ° C because of their enhanced metabolic activity, [ 10 ] 
which was demonstrated for the fi rst time in Uchiyama’s group 
using an organic fl uorophore-contained nanogel as an intra-
cellular thermometer. [ 11 ] Integration of thermometry with the 
thermally/photothermally controllable drug release into a single 
nano-platform can contribute to the explanation of intricate bio-
logical processes and the development of novel diagnoses and 
therapies. [ 12 ] Although considerable research efforts have been 
put into various fi elds, unfortunately, no report of any drug car-
riers drawing the merits of both QDs (high quantum yielded 
fl uorescence) and Au (plasmonics) for common progress has 
appeared in the literature. 
 Retaining the unique properties of each building block 
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the plasmonic property of metals such as Au. [ 14 ] The combina-
tion of QD fl uorescence with Au plasmonics has been demon-
strated on fl at surfaces. [ 15 ] However, the direct growth of Au 
onto single QDs, quantum rods or tetrapods usually leads to 
a quenching in either the photonics or plasmonics of the con-
structed QD-Au NPs. [ 13 , 16 ] Very recently, inspired by the biomin-
eralization of Au, [ 17 ] Jin and Gao successfully combined the fl u-
orescence and plasmonics into a single Au-shell-encapsulated 
CdSe/ZnS QD by using poly(ethylene glycol) (PEG)-based linear 
polymer chains as a structural scaffold. [ 2 a] The spacing between 
the QD core and Au shell was controlled by engineering the 
polymer intermedius through layer-by-layer assembly. As a con-
sequence, a high photoluminescence quantum yield (PLQY) of 
 ≥ 39% of the QDs and a strong surface plasmon scattering of 
the Au shell were simultaneously achieved, making the nano-
platform an excellent dual-modality imaging agent. 
 In this work, we design a thermoresponsive nonlinear PEG-
based polymer nanogel network to act as a three-dimensional 
(3D) scaffold to integrate ZnO QDs and metallic Au into a 
single hybrid nanogel particle ( < 100 nm). As schematically 
depicted in  Figure  1 a – coupled with a specifi c physiochem-
ical characteristic, the disruption in homeostasis of local 
temperature – the newly designed nanoplatform combining the 
building blocks of fl uorescent QDs, plasmonic metal Au, and 
responsive polymer gels should provide great potential for bio-
medical applications. We demonstrate that the tri-component 
hybrid nanogels, denoted as ZnO-Au@PEG, display coopera-
tive properties while maintaining the individual properties of 
each constituent, thus allowing the integration of three impor-
tant applications: ratiometric fl uorescent sensing of tempera-
ture change in physiological fl uid, fl uorescent cell imaging, 
and thermal/photothermal-regulated drug delivery. Unlike 
our previously studied biosensors with CdSe QDs physically 
restricted in polysaccharide-based gel networks, [ 5 ] the newly 
developed hybrid nanogels with ZnO QDs covalently bonded 
to the PEG-based gel network chains can prevent the liberation 
of QDs when applied for analysis of biological fl uids under var-
ying environments, thus providing high sensitivity and long-
term reproducibility. A stable and highly accurate photolumi-
nescence (PL) response is important for future in situ studies 
in bio-systems. Furthermore, concerning the long-term toxicity 
that may be caused by the release of Cd ions from cadmium-
based QDs, ZnO QDs are believed to be more versatile for 
bio-applications. [ 4 b, 4 c] Inspired by Uchiyama’s intracellular © 2011 WILEY-VCH Verlag GmAdv. Funct. Mater. 2011, 21, 2830–2839
 Figure  1 .  a) Model of the tri-component responsive hybrid nanogels for mu
cations in biomedicine. b) Typical TEM image of ZnO-Au@PEG hybrid nanthermometer, [ 11 ] we anticipate that the novel ZnO-Au@PEG 
hybrid nanogels could be potentially used as intelligent fl uo-
rescent labels to monitor local temperature changes in tumors, 
standing in contrast against conventional labels, which are 
insensitive to local environmental change. In addition, hybrid 
nanogels could also be developed for simultaneous chemo and 
photothermal cancer treatment, where either the local patho-
logical temperature change (endogenous activation) or NIR-
induced localized hyperthermia (exogenous activation) can 
provide spatiotemporal control of the release of the anticancer 
drug temozolomide (TMZ) from the hybrid nanogel carriers. 
The interdisciplinary design and development of multifunc-
tional intelligent nano-platforms would pave a new path in bio-
logical manipulation, medical diagnosis and therapy. 
 2. Results and Discussion 
 2.1. Synthesis and Structure of ZnO-Au@PEG Hybrid Nanogels 
 The strategy to prepare the multifunctional ZnO-Au@PEG 
hybrid nanogels involves fi rst the synthesis of ZnO@PEG 
hybrid nanogels, followed by a moderate growth of Au nano-
clusters inside the hybrid nanogels. The ZnO@PEG hybrid 
nanogels were synthesized from the copolymerization of zinc 
methacrylate (Zn(MAA) 2 ), 2-(2-methoxyethoxy)ethyl methacr-
ylate (MEO 2 MA), oligo(ethylene glycol)methyl ether meth-
acrylate (MEO 5 MA), and a crosslinker poly(ethylene glycol) 
dimethacrylate (PEGDMA) in ethanol and then transferred 
into aqueous solution. In the FTIR spectrum ( Figure  2 a), the 
characteristic absorption for the bridging coordination modes 
of acetate group with Zn appears at 1600 cm  − 1 (C = O) and 
1443 cm  − 1 (C − O), [ 4 b, 4 c, 18 ] respectively, indicating that ZnO QDs 
were covalently connected to the gel network chains. The signal 
at about 1726 cm  − 1 is assigned to the  − COOR and  − COOH 
groups, and the broad band at 1050–1150 cm  − 1 (C − O − C) is 
associated with the PEG chains. The covalently immobilized 
ZnO QDs can emit a relatively weak near-UV light (393 nm, 
assigned to exciton recombination) and a strong yellow-green 
light (530 nm, vacancy PL) in aqueous solution (Figure  2 b). 
To introduce Au into the nanogels, HAuCl 4 was used as the 
precursor. Wang et al. [ 16 b] found that citrate-capped ZnO nano-
crystals could act as centers for the reduction of Au(III) by 
citrate and then form nucleation sites for reduced Au atoms; 
however, no reaction was observed in the citrate/HAuCl 4 solu-bH & Co. KGaA, Weinh
ltifunctional appli-
ogels (ZAG-2). tion in the absence of ZnO nanocrystals. In 
our case, the ZnO QDs covalently immobi-
lized in the nanogel networks were applied 
as nucleation sites for the growth of metallic 
Au to synthesize ZnO-Au@PEG hybrid 
nanogels under dark and in an ice bath. The 
control experiment indicated that the reduc-
tion of Au(III) to Au(0) is very slow in water 
or in the dispersion of the nonlinear PEG-
based nanogels that contain no ZnO QDs (at 
least no evidence was observed in UV–vis–
NIR spectra after a week), which minimizes 
the rapid nucleation of monometallic Au 










 Figure  2 .  a) Typical FTIR spectra, b) PL profi les, and c) UV–vis–NIR 
absorption spectra of ZnO@PEG and ZnO-Au@PEG hybrid nanogels 
(ZAG-2) recorded at room temperature. unassociated with ZnO QDs. Interestingly, as shown in 
Figure  2 c, the metallic Au incorporated in our hybrid nanogels 
exhibited a typical SPR band at aroudn 525 nm and trailed to 
NIR region, standing in vivid contrast against the faintly seen 
SPR in the directly coupled ZnO-Au NPs. [ 16 b] FTIR spectroscopy 
indicated a slight split in the IR signals of C = O in the  − COOZn 
and  − COOH groups for our ZnO-Au@PEG hybrid nanogels. 
However, no evident change was observed for the C − O or 
C − O − C signals. These results suggested a higher accessibility 
of Au(III) ions and subsequently the growth of metallic Au on 
the C = O regions than on the C − O or C − O − C regions. Nev-
ertheless, the obtained ZnO-Au@PEG hybrid nanogels show © 2011 WILEY-VCH Verlag Gwileyonlinelibrary.comgreat stability. No sediment was observed even after 6 months 
storage at room temperature (approximately 22  ° C). Only a 
marginal change in UV–vis–NIR absorption can be detected 
for both ZnO and Au (see Figure S1 in the Supporting Infor-
mation), implying that the size of ZnO and Au remained 
unchanged during storage. The stable SPR of ZnO-Au@PEG 
hybrid nanogels are desirable for their successful use in NIR-
controlled drug release. 
 A key question was then whether the ZnO QDs in 
ZnO-Au@PEG hybrid nanogels would remain fl uorescent. 
As shown in Figure  2 b, a slight enhancement in 393 nm 
emission accompanied by a quenching in 530 nm emission 
was observed for ZnO-Au@PEG hybrid nanogels, in com-
parison with ZnO@PEG hybrid nanogels. The emission peak 
positions did not shift. It is known that the optical property of 
a material is closely associated with its electronic structure. At 
short separation distance and signifi cant overlap between QD 
emission and Au SPR bands, Au NPs have been demonstrated 
as fl uorescence quenchers of QDs. [ 2 a, 13 , 16 ] The Fermi energy 
level of Au is higher than that of ZnO due to the smaller work 
function of Au (5.1 eV) than ZnO (5.2–5.3 eV), [ 16 a] so that the 
electron transfer from Au to the closely contacted ZnO would 
occur until the two systems attain equilibration. Considering 
that surface plasmon energy of metal Au matches well with 
the emitted visible photon energy of ZnO QDs, the emitted 
photons can produce the surface plasmon through energy 
transfer, which promotes electrons in Au to an excited state 
by a surface plasmon wave. The excited electrons will sub-
sequently tunnel into the conduction band of ZnO parts. A 
similar but more signifi cant spectral change has been observed 
on the ZnO-Au composites, in which the near-UV emission 
was enhanced by one order of magnitude compared to that 
of pure ZnO NPs, accompanied by a weakened visible emis-
sion to about two-thirds that of pure ZnO NPs. [ 16 b] In contrast, 
with the polymer gel network serving as a 3D scaffold, the 
ZnO QDs in the ZnO-Au@PEG hybrid nanogels showed only 
a slightly decreased PLQY at 530 nm and a similar PLQY at 
390 nm as compared to the ZnO QDs in the template ZnO@
PEG hybrid nanogels. In comparison with other Cd-free 
QDs, [ 4 d, 4 e] the ZnO QDs in the ZnO-Au@PEG hybrid nano-
gels still possess a considerably high PLQY (approximately 
23%) at 530 nm. 
 The transmission electron microscopy (TEM) images show 
that ZnO-Au@PEG hybrid nanogels are nearly spherical 
and smaller than 100 nm in size (Figure  1 b for ZAG-2, see 
Figure S2 in the Supporting Information for others). The 
overall size of the four hybrid nanogels ZAG-1 (45 nm), ZAG-2 
(58 nm), ZAG-3 (76 nm), and ZAG-4 (98 nm) correspondingly 
increased when the feeding of the MEO 5 MA monomers was 
gradually increased while the amount of MEO 2 MA was fi xed 
during synthesis. On the basis of physiological parameters, 
such as hepatic fi ltration, tissue extravasation, tissue diffu-
sion, and kidney excretion, it is clear that carrier particle size 
is a key factor to achieve long circulation for good biodistribu-
tion and high therapeutic effi cacy. [ 19 ] NP-based drug carriers in 
the size range of 10–100 nm have actual advantages to improve 
the blood circulation time and enhance the extravasation rate 
into permeable tissues such as tumors. [ 19,20 ] Since the polymer 








 Figure  3 .  a) Temperature dependence of the average  R h values, and, 
b) swelling ratio,  R h ( T )/ R h (15.5  ° C), of ZnO-Au@PEG hybrid nanogels 
ZAG-1 (  ), ZAG-2 ( • ), ZAG-3 (  ), and ZAG-4 (  ) in PBS of pH  = 7.4, 
measured at a scattering angle  θ  = 90 ° . TEM image is a 2D projection for a 3D distribution of the ZnO 
QDs/Au inside the nanogels, the structure of the immobilized 
QDs/Au cannot be seen clearly. As the size of QDs is directly 
related to the excitonic peak in the UV–vis–NIR absorption 
spectrum, the size of ZnO QDs can be estimated by empirical 
functions reported by Meulenkamp. [ 21 ] The typical  λ ½ of ZnO 
QDs (Figure  2 c), the wavelength at which the absorption is 
50% of that at the excitonic peak (or shoulder), is determined 
as about 348 nm for all the studied samples before and after 
the growth of Au, from which the average size of ZnO QDs was 
calculated to be about 3.5 nm. 
 2.2. Temperature-Induced Volume Phase Transition 
 The ZnO-Au@PEG hybrid nanogels can undergo a reversible 
temperature-responsive volume phase transition ( Figure  3 ). 
The swelling/deswelling characteristic is a consequence of the 
counterbalance of the hydrophilic and hydrophobic forces in 
the nanogels at particular temperatures. The polymers made 
from MEO 2 MA and MEO 5 MA have lower critical solution © 2011 WILEY-VCH Verlag GAdv. Funct. Mater. 2011, 21, 2830–2839temperatures (LCST) of about 24 and 61  ° C, respectively. The 
equilibrium swelling ratio of the copolymerized gel networks can 
be regulated by the feeding molar ratio  r mol  =  n MEO2MA / n MEO5MA 
in the synthesis, leading to a shift in the critical volume phase 
transition temperature (VPTT) of the hybrid nanogels. [ 9 b, 22 ] The 
higher the  r mol , the lower the VPTT of the hybrid nanogels. 
While ZAG-1 ( r mol  = 2.21) and ZAG-4 ( r mol  = 0.65) exhibited 
a VPTT at approximately 34 and  > 50  ° C, respectively, a proper 
control of  r mol in ZAG-2 ( r mol  = 1.31) and ZAG-3 ( r mol  = 0.89) 
resulted in a continuous change in hydrodynamic radius ( R h ) 
but of tunable slopes across the physiologically important tem-
perature range of 37–42  ° C that are found in many pathological 
zones, such as in tumors. [ 10,11 ] 
 2.3. Temperature-Sensitive PL Property of ZnO-Au@PEG 
Hybrid Nanogels 
 Having demonstrated that ZnO-Au@PEG hybrid nanogels 
could retain the QD fl uorescence, Au plasmonics, and PEG 
thermosensitivity after nanoscale integration, we next examine 
the cooperation of these properties for multifunctional applica-
tions. The responsive ZnO-Au@PEG hybrid nanogels can con-
vert the temperature changes into optical signals in terms of 
the visible emission intensity change of ZnO QDs ( Figure  4 ). 
Simply placed in a container and irradiated with a 375 nm 
UV lamp, the hybrid nanogel dispersions exhibit different 
color at 15.5 and 50.0  ° C, observable by the naked eye (photo-
graphs in Figure S3 in the Supporting Information). More 
robust signals can be obtained by using the enhanced PL inten-
sity  I ( T )/ I (15.5  ° C), where  I ( T ) is the PL intensity at 530 nm 
recorded at different temperature  T . In comparison with the 
 R h –temperature plot (Figure  3 b), the  I ( T )/ I (15.5  ° C) reveals 
nearly the same trend towards temperature change (Figure  4 b), 
clearly correlating the temperature-induced volume change of 
the nanogel to the PL response of QDs. Two factors should be 
considered to explain how the temperature-induced shrinking of 
nanogels could trigger the PL enhancement of the immobilized 
QDs. One is related to an increase in the local refractive index 
around the QDs during the collapse of the nanogel, which could 
affect the quantum effi ciency of QDs. [ 23 ] Another is related to 
the variation of the strain at the surface of QDs. At low tem-
peratures, the cross-linked structure hinders the volume expan-
sion at a high swelling state, creating elastic tensions localized 
at the cross-linking points. Because the ZnO QDs are covalently 
bonded to the polymer chains, the QDs also act as cross-linking 
points. Thus, the elastic tension will propagate to the surface of 
the QDs, producing surface quenching states. [ 24 ] The increase 
in temperature induces the gel to shrink, which can diminish 
the elastic tension and consequently reduce the number of 
quenching centers, leading to an enhancement in PL intensity. 
The optical response is completely reversible (Figure  4 c). Since 
the PL response is triggered by the volume phase transition of 
the nanogels, the kinetics of the PL response will depend on how 
fast the volume phase transition is. The rate of stimuli-induced 
volume phase transition of a hydrogel particle is scaled as  l  − 2 , 
where  l is the relevant length of gel particle. [ 25 ] Nanosecond to 
microsecond (approximately 100 ns) volume phase transitions 










 Figure  4 .  a) Typical PL spectra of ZnO-Au@PEG hybrid nanogels (ZAG-2) 
at different temperatures. Scans were taken at 1.5  ° C intervals from 
bottom to top, from 15.5 to 50.0  ° C. b) The temperature-induced PL inten-
sity enhancement,  I ( T )/ I (15.5  ° C), measured at 530 nm. c) Enhanced PL 
of the hybrid nanogels during repeated heating (50.0  ° C) and cooling 
(15.5  ° C) cycles. All measurements were made in 0.005  M PBS of pH  = 
7.4. Excitation wavelength  = 340 nm. poly( N -isopropylacrylamide) nanogel particles in the size range 
of around 200–350 nm. [ 26 ] The kinetics of the temperature-
induced phase transition of the sub-100 nm ZnO-Au@PEG 
hybrid nanogels should be in the 100 ns scale or even faster. © 2011 WILEY-VCH Verlag G4 wileyonlinelibrary.comThus, our hybrid nanogels should be able to undergo a very 
fast PL response to a temperature change. Furthermore, with 
a precision of  ± 1% in the determination of the PL intensity, a 
temperature resolution of  ± 0.18–0.24  ° C can be achieved for 
ZAG-2 over the range 37–42  ° C, which is very close to the one 
achieved on the conformational response of a temperature-
responsive polymer chain. [ 27 ] The temperature resolution or 
the sensitivity of PL response can be fi ne-tuned through the 
control of the temperature-responsive volume phase transition 
of the PEG-based networks (Figure  4 b). In comparison with 
previously studied hybrid nanogels with the QDs/NPs physi-
cally restricted in the interior of the polymer networks, [ 5 , 9 b] the 
present ZnO-Au@PEG hybrid nanogels demonstrate a much 
higher sensitivity of PL response, possibly due to the rapid and 
sensitive transmission of the elastic tension directly from the 
polymer chains to the covalently bonded QDs. The rapid and 
highly accurate PL response will be an important feature for 
future in situ studies in biosystems. 
 To examine the potential interference from ion strengths, 
NaCl was used as an ion source to mimic intracellular condi-
tions, as Na  +  (approximately 0.010  M) is the only component of 
the cellular growth medium required for the development and 
disappearance of vacuoles. [ 28 ] When the NaCl concentration 
increased from 0 to 0.200  M (Figure S3), an almost identical PL 
response to the temperature variation was obtained with a rela-
tive error less than  ± 0.52% over the range 37–42  ° C, demon-
strating a minimal impact of the ion strength on the signaling 
ability of the hybrid nanogels. The interference can be further 
eliminated when the enhanced PL intensity is expressed as the 
ratio of  I ( T )/ I (15.5  ° C) to evaluate the PL response. Similarly, 
the PL response was nearly independent of the environmental 
pH over 5.0–7.4 ( ± 0.19%, Figure S4). This feature is desirable 
because the extracellular pH of a tumor environment and endo-
somal/lysosomal pH lie at approximately 7–6.5 and 6.5–5.0, 
respectively. [ 10 ] Therefore, high sensitivity and high selectivity 
for temperature sensing over a physiological range could be 
achieved on our Zn ZnO-Au@PEG hybrid nanogels. 
 2.4. Drug Loading and in vitro Thermal- and 
Photothermal-Regulated Drug Release 
 Three hybrid nanogels of ZAG-2, ZAG-3, and ZAG-4 with 
high temperature sensitivity over the physiological tempera-
ture range were selected for further in vitro experiments. 
TMZ, a new imidazole tetrazinone compound (Figure S5) 
with promising preclinical and clinical activity in nitrosourea-
sensitive and nitrosourea-resistant models and manage-
able toxicity in phase I/II clinical trials, [ 29 ] was selected as a 
model drug for uploading into the hybrid nanogels (purifi ed 
at 22  ° C). With the high porosity of the gel and the hydrogen 
bonding interaction between the ether oxygens of PEG chains 
and the amide groups of TMZ, high drug loading capacities of 
43.6, 48.9 and 55.3 wt-% were achieved for ZAG-2, ZAG-3 and 
ZAG-4, respectively. Fluorescent microscopy indicates that the 
drug-loaded hybrid nanogels still show strong fl uorescence. 
TMZ has a negligible effect ( + 1.7%) on the PL enhance-
ment ( I ( T )/ I (15.5  ° C)) of the hybrid nanogels over the range 








 Figure  5 .  Release profi les of TMZ from ZnO-Au@PEG hybrid nanogels: a) ZAG-2, b) ZAG-3, and c) ZAG-4 in PBS at pH  = 7.4 at different temperatures 
(22  ° C:   ; 37  ° C: • ; 39  ° C:  ; 41  ° C:   ). The lines are based on the fi tting of Peppas’s Model:  M t / M  ∞   =  kt n . d) Release profi les of TMZ from ZAG-2, ZAG-3, 
and ZAG-4 immersed in PBS of pH  = 7.4 at a constant temperature of 37  ° C, upon exposure to 5 min of 1.5 W cm  − 2 NIR light for 0, 4, and 8 h.  Two approaches can be used to regulate the release of the 
pre-loaded TMZ from the hybrid nanogels. First, the increase in 
temperature of the releasing medium can speed up the release 
( Figure  5 a–c). The releasing rate can be further tailored by engi-
neering the phase behavior of the hybrid nanogels. ZAG-2, 
ZAG-3, and ZAG-4 with a gradual increase in VPTT exhibit 
a gradually decreased releasing rate. The releasing profi les fi t 
well to Peppas’s model: [ 30 ] 
 Mt /M∞ = ktn  
 where  M t and  M  ∞  are the cumulative amount of drug released 
at time  t and infi nite time, respectively,  k is a structural/geo-
metric constant, and  n is related to the intimate mechanism of 
release. The calculated  n values are all below the critical value 
of 0.43, [ 30 ] which indicates that the release from the sphere-
like hybrid nanogels obeys two correlated processes: one is 
related to the breakage of hydrogen bonds between the drug 
and the gel network chains; another is a diffusion-controlled 
step. The increase in temperature from 22 to 41  ° C increased © 2011 WILEY-VCH Verlag GAdv. Funct. Mater. 2011, 21, 2830–2839the  n value, but did not change the drug release mecha-
nism. Such a temperature-dependent release profi le may be 
exploited for biologically controlled drug release utilizing the 
abnormal temperature increase in pathological zones. [ 10,11 ] 
Drug release by a stepwise treatment also can be achieved 
after further modifi cation, for example, simply by purifying 
the drug-loaded carriers at the normal temperature of 37  ° C 
(Figure S5). 
 Second, NIR light can provide a highly orthogonal external 
stimulus, allowing spatiotemporally controlled release. The metal 
Au can absorb and convert NIR light into heat on a picosecond 
time scale, as a result of electron–phonon and phonon–phonon 
processes. [ 7 ] The heat will dissipate into the surroundings, and the 
rise in local temperature causes the shrinking of the gel networks, 
thereby accelerating the release of pre-loaded TMZ (Figure  5 d), 
in comparison to cases without NIR irradiation. When the lamp 
is turned off, heating will immediately cease. The decrease in 
temperature will bring the polymer chains back to its original 
extended conformation, thus the drug release returns to its reg-










 Figure  6 .  Scanning confocal images of B16F10 cells incubated with ZnO-Au@PEG hybrid 
nanogels: a) ZAG-2, b) ZAG-3, and c) ZAG-4. Excitation wavelength 405 nm. 1.5 W cm  − 2 ) caused little temperature increase (far less than 1  ° C) 
in the releasing medium. Such an NIR-triggered drug release 
should remarkably enhance the ability of our hybrid nanogels for 
specifi c drug delivery to the tumor site. Depending on the stage 
and type of cancer, this NIR-accelerated drug release can provide 
high dosage at a shorten treatment time if necessary. 
 2.5. Cell Internalization and Cell Viability of in vitro Chemo, 
Photothermal, and Chemo-photothermal Treatments 
 The ZnO–Au@PEG hybrid nanogels can emit strong vis-
ible fl uorescence under the physiological conditions, which 
renders them useful for biomedical detection of the drug car-
riers and imaging diagnosis. Laser confocal microscopy was 
used to evaluate whether these hybrid nanogels could be used 
for tumor cell imaging. The hybrid nanogels show bright and 
colorful spots in the fl uorescent imaging, while no signifi cant 
autofl uorescence was observed on the mouse melanoma cells 
B16F10. After incubation of the cells with the hybrid nano-
gels for 24 h, the difference in colors refl ected the fact that 
the hybrid nanogels can penetrate into the living cells and 
exhibit bright fl uorescence ( Figure  6 , also see Figure S6 and 
S7 in the Supporting Information), which can retain nearly the 
same PL intensity even after 20 min irradiation. These bright 
spots are mainly distributed in the cytoplasm and perinuclear 
region of the cells. As the complexity of molecular interactions © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Wei6 wileyonlinelibrary.comgoverning endocytosis are revealed, the 
mechanisms of endocytosis should be viewed 
in a broader context than simple vesicular 
traffi cking. [ 9 b, 20 b, 31 ] When the size of NPs is 
smaller than 100 nm, the biological pathways 
in cells can undergo profound changes. [ 31 ] 
Moreover, PEG chains are known to be able 
to serve as effi cient steric protectors for 
various particulates (such as micelles, lipo-
somes, and NPs) in biological media. [ 32 ] It 
has been reported that small-sized ( < 100 nm) 
PEG-phosphatidylethanolamine micelles can 
attain deep penetration into poorly perme-
able tumors. [ 20 a] Nevertheless, it is obvious 
that these hybrid nanogel probes do not 
give dark regions in the cell, and simply 
areas where the nanogel did not permeate 
are clear, rendering them suitable for cell-
labelling markers. Combining with the 
fl uorescent signaling ability, one possible 
application of the hybrid nanogels is for 
intracellular sensing and imaging of tem-
perature, which may be termed as intelligent 
labelling. It should be mentioned that our 
current experimental setup cannot record 
the intracellular temperature. Intracellular 
thermometry has been achieved on Uchiya-
ma’s instruments. [ 11 ] 
 A beautiful characteristic of ZnO-Au@
PEG hybrid nanogels for future biological 
applications, especially for clinical applica-
tions, is the low cytotoxicity of each compo-nent. In Figure  6 , no signs of morphological damage to the 
B16F10 cells were observed upon treatment with the hybrid 
nanogels, demonstrating minimal cytotoxicity. This was fur-
ther supported by the fact that more than 95% of B16F10 
cells can survive upon treatment with the hybrid nanogels 
with concentrations up to 114.6, 102.2 and 90.4  μ g mL  − 1 for 
ZAG-2, ZAG-3 and ZAG-4, respectively (Figure S8). In con-
trast, the cell viability drastically decreased when the cells 
were treated with TMZ-loaded ZAG-2, ZAG-3 and ZAG-3 
even at concentrations as low as 11.5, 10.2 and 9.0  μ g mL  − 1 , 
respectively (equivalent to 25.8  μ M free TMZ). These results 
indicate that the TMZ-loaded hybrid nanogels provide a 
high anticancer activity. The cytotoxicity of TMZ-loaded 
hybrid nanogels is lower than that of free TMZ solution at 
all the studied concentrations. This can be attributed to the 
sustained-release property of the TMZ-loaded hybrid nano-
gels. Considering that less than 40% of the loaded TMZ was 
released in 24 h under physiological conditions (Figure  5 ), the 
slightly lower cytotoxicity of the TMZ-loaded hybrid nanogels 
than the free TMZ solutions is understandable. 
 To investigate the effect of combined chemo-photothermal 
treatment, the cell viability was measured when the B16F10 
cells were treated with drug-free and TMZ-loaded hybrid 
nanogels for 24 h, respectively, but adding 5 min initial NIR 
irradiation. The addition of initial 5 min NIR irradiation 
has a neglectable effect on the cytotoxicity of the free TMZ 
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 Figure  7 .  Therapeutic effi cacies of photothermal, chemo, and combined 
chemo-photothermal treatments with ZnO-Au@PEG hybrid nanogels 
a) ZAG-2, b) ZAG-3, and c) ZAG-4 as drug carriers calculated by sub-
tracting cell viability from 100%. Additive therapeutic effi cacies of chemo 
and photothermal treatments were estimated using the relation of  T additive  = 
100 – ( f chemo  ×  f photothermal )  × 100, where  f is the fraction of surviving cells 
after each treatment. The effi cacy of combined treatment is compared 
with the additive effi cacy of independent chemo- and photothermal treat-
ments using  t- tests with all  p -values lower than 0.05. hybrid nanogels as drug carriers, the combined TMZ and 
photo thermal treatment exhibited much higher therapeutic 
effi cacy (calculated by subtracting the cell viability from 100%) 
than the chemotherapy or photothermal treatment alone 
( Figure  7 ). The effi cacy of the combined TMZ-photothermal 
treatments is also signifi cantly higher than the additive 
therapeutic effi cacy of chemo- and photothermal treat-
ments, which were estimated using the relation of  T additive  = 
100 – ( f chemo  ×  f photothermal )  × 100 with  f being the fraction of 
surviving cells after each treatment. [ 33 ] When a  t -test is used 
to compare the effi cacy of combined treatment with the effi -
cacies of chemo- and photothermal treatments and their 
additive value, all  p -values are lower than 0.05, indicating a 
signifi cant difference. Clearly, the synergistic effect of chemo-
photothermal treatment is demonstrated on ZnO-Au@PEG 
hybrid nanogels. 
 3. Conclusions 
 We have developed an advanced multifunctional nanoplatform 
that can be constructed by using polymer nanogel as a 3D scaf-
fold to covalently bond ZnO QDs onto the thermoresponsive 
PEG-based gel network chains, and then appropriately growing 
metallic Au in the interior of the nanogels. Different to other 
examples of QD/NP-loaded nanogel colloids or QD/Au hetero-
junction structures in which metallic Au signifi cantly quenched 
the fl uorescence of QDs, the beauty of the newly developed 
ZnO-Au@PEG hybrid nanogels is that they can successfully 
integrate the strong fl uorescence (PLQY  ≈ 23%) of ZnO QDs, 
SPR of metal Au, and thermosensitivity of nanogel into a single 
sub-100 nm nano-object. As a result, these hybrid nanogels can 
simultaneously act as high-resolution biosensors for tempera-
ture sensing, fl uorescent agents for tumor-cell imaging, and 
smart drug carriers for synergistic chemo-photothermal treat-
ment. These multifunctional hybrid nanogels should promise a 
new effi cient modality for broad applications in high-resolution 
temperature sensing-related techniques, as well as for in vivo 
animal models and future clinical trials in cancer diagnosis, 
therapy, and monitoring. We envision that the approach pre-
sented here may open new possibilities to bridge the unique 
properties of different materials to leverage research both fun-
damentally and practically, using a variety of interdisciplinary 
combinations. 
 4. Experimental Section 
 Materials : All chemicals were purchased from Aldrich. MEO 2 MA, 
MEO 5 MA (M n  = 300 g mol  − 1 ) and PEGDMA (M n  ≈ 550 g mol  − 1 ) were 
purifi ed with neutral Al 2 O 3 . 2,2 ′ -Azobisisobutyronitrile (AIBN) was 
purifi ed by recrystallization from anhydrous ethanol. TMZ, Zn(MAA) 2 , 
HAuCl 4 · 3H 2 O, NaCl, and trisodium citrate were used as received without 
further purifi cation. The water used in all experiments was of Millipore 
Milli-Q grade. 
 Synthesis of ZnO@PEG Hybrid Nanogels : Zn(MAA) 2 (1.28 mmol), 
MEO 2 MA (12.00 mmol), MEO 5 MA, and PEGDMA (0.18 mmol) were 
dissolved in anhydrous ethanol (25 mL) in a 100 mL round-bottom fl ask 
equipped with a stirrer and a condenser. The solution was stirred and 
heated to 80  ° C, and then AIBN (0.41 mmol) was added. After refl uxing 









www.MaterialsViews.comaqueous solution was added into the reaction system and continuously 
refl uxed for another 1 h. After cooling to room temperature, the product 
was purifi ed by centrifugation (20 000 rpm, 30 min, 35  ° C, Thermo 
Electron Co. Sorvall RC-6 PLUS superspeed centrifuge), redispersion in 
water, and 3 d dialysis (Spectra/Por molecularporous membrane tubing, 
cutoff 12 000–14 000) against water. Four ZnO@PEG hybrid nanogels 
were prepared by changing the feeding amount of MEO 5 MA to 5.42, 
9.16, 13.55, and 18.34 mmol, respectively. 
 Synthesis of ZnO-Au@PEG Hybrid Nanogels : The purifi ed ZnO@PEG 
hybrid nanogels (50 mL) in a 150 mL glass vial were stirred in an ice 
water bath for 30 min, trisodium citrate (2.5 mL, 30 mmol L  − 1 ) was then 
added dropwisely to the vial. HAuCl 4 solution (1 mL, 25 mmol L  − 1 ) was 
slowly dropped into the above solution while vigorously stirring for 24 h 
at room temperature until the color was stable. During this period, the 
solution changed from light white to wine red and became transparent, 
which indicated that Au particles have been formed. The resulted 
ZnO-Au@PEG hybrid nanogels were purifi ed with centrifugation/
redispersion in water for three cycles, followed by 3 d of dialysis against 
very frequently changed water. Four samples were prepared with the 
variable feeding of MEO 5 MA at 5.42 mmol (ZAG-1), 9.16 mmol (ZAG-2), 
13.55 mmol (ZAG-3), and 18.34 mmol (ZAG-4). 
 Drug Loading and Release : TMZ was loaded into ZnO-Au@PEG hybrid 
nanogels by complexation. The pH value of hybrid nanogel (5 mL) was 
adjusted to 4.0 by using HCl solution (0.1  N ). This dispersion was stirred 
in an ice water bath for 30 min. TMZ solution (500  μ L, 1 mg mL  − 1 , 
pH  = 2.0) was then added dropwisely to the vial. The hydrogen bonding 
complexation of TMZ molecules with PEG chains caused an immediate 
slightly cloudy solution. After stirring overnight, the suspension was 
centrifuged at 20 000 rpm for 30 min at 22  ° C. To remove free TMZ, 
the precipitate was redispersed in HCl solution (5 mL, pH  = 4.0), and 
further purifi ed by repeated centrifugation and washing. All the upper 
clear solutions were collected, and the concentration of free TMZ was 
determined by UV–vis spectrometry at 328 and 260 nm, based on the 
linear calibration curve with  R 2  > 0.99 measured using the TMZ solutions 
with known concentrations under the same condition. The amount of 
TMZ loaded into hybrid nanogels was calculated from the decrease in 
TMZ concentration. The loading content is expressed as the mass of 
loaded drug per unit weight of dried hybrid nanogels. 
 The in vitro release test of TMZ from ZnO-Au@PEG hybrid nanogels 
was evaluated by the dialysis method. A dialysis bag fi lled with purifi ed 
TMZ-loaded hybrid nanogel dispersion (5 mL, pH  = 4.0) was immersed 
in buffer solutions (50 mL, 0.005  M , pH  = 7.4) at different temperatures. 
To examine the photothermal effects on the releasing rate, 5 min NIR 
(1.5 W cm  − 2 ) irradiation at certain time intervals was applied to the 
releasing samples. The released TMZ outside of the dialysis bag was 
sampled at defi ned time period and assayed by UV–vis absorption at 
both 328 and 260 nm. Cumulative release is expressed as the total 
percentage of drug released through the dialysis membrane over time. 
 Incorporation of the Hybrid Nanogels into B16F10 Cells : Round glass 
coverslips were placed in wells of a 24-well plates and treated with 0.1% 
poly- L -lysine in phosphate buffered saline (0.100  M ) for 40 min. Following 
the treatment, the solution was aspirated and the wells were washed with 
PBS three times each. Next, B16F10 cells (2  × 10 5 cell well  − 1 ) were plated 
on the glass coverslips at 80% confl uence in DMEM containing 10% 
FBS and 1% penicillin-streptomycin. After 24 h, different ZnO-Au@PEG 
hybrid nanogels (500  μ L, 3.0  μ g mL  − 1 ) in serum-free DMEM were added 
to the marked wells. In a control well, serum-free DMEM (500  μ L) was 
added. The plate was incubated at 37 ° C for 24 h. The medium was then 
aspirated and fresh serum-free DMEM was added to each well. Finally, 
the coverslips with cells were removed from the wells and mounted onto 
slides. 
 Cell  Viability Evaluation : B16F10 cells (6  × 10 4 cell well  − 1 ) were 
cultured in DMEM containing 10% FBS and 1% penicillin-streptomycin 
in a 96-well plate, and exposed to free TMZ, empty hybrid nanogels, 
and TMZ-loaded hybrid nanogels. To cover the high concentrations, 
the nanogels were concentrated and adjusted to an appropriate 
concentration in DMEM right before feeding into the well. Then, the cells 
were irradiated with 1.5 W cm  − 2 NIR light for 5 min for photothermal © 2011 WILEY-VCH Verlag wileyonlinelibrary.comand chemo-photothermal treatments, while maintaining an average 
solution temperature of approximately 37  ° C. For chemotherapy alone, 
the cells were not exposed to NIR light. The plate was incubated at 37  ° C 
for 24 h. The medium was then aspirated, and these wells were washed 
three times using fresh serum-free DMEM. After that, 3-(4,5-dimethyl-
2-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT) solution (25  μ L, 
5 mg mL  − 1 in PBS) were added to the wells. After incubation for 2 h, the 
solution was aspirated and DMSO (100  μ L) was added to each well to 
dissolve the formazan crystal, and the plate was sealed and incubated 
overnight at 37  ° C with gentle mixing. Three portions of the solution 
obtained from each well were transferred to three respective wells of a 
96-well plate. Cell viability was measured using a microplate reader at 
570 nm. Positive controls contained no drug or nanogels, and negative 
controls contained MTT. Parallel wells (in triplicate) also contained only 
medium (no cells) and the same concentrations of hybrid nanogels. 
 Characterization : UV–vis–NIR absorption spectra were obtained on a 
Thermo Electron Co. Helios  β UV–vis spectrometer. PL spectra of the 
hybrid nanogel dispersions at different temperatures were respectively 
obtained on a Jobin Yvon Co. FluoroMax-3 Spectrofl uorometer equipped 
with a Hamamatsu R928P photomultiplier tube, calibrated photodiode 
for excitation reference correction from 200 to 980 nm, and an integration 
time of 1 s. To confi rm all emissions, PL spectra were also recorded on 
a Varian Cary Eclipse Fluorescence spectrophotometer equipped with 
R928 photomultiplier tubes and self-optimized light fi lters. The pH values 
were measured on a Mettler Toledo SevenEasy pH meter. TEM images 
were taken on a FEI Tecnai transmission electron microscope at an 
accelerating voltage of 120 kV. Cell imaging were conducted on a confocal 
laser scanning microscopy (Leica TCS SP2 AOBS) equipped with a HC PL 
APO CS 20  × 0.7 DRY len, and a UV (405 nm) light as the light source. 
Dynamic light scattering (DLS) was performed on a 90Plus multi-angle 
particle sizing analyzer equipped with a BI-9000AT digital autocorrelator 
(Brookhaven Instruments, Inc.) to measure the  R h distributions. A He–Ne 
laser (35 mW, 659 nm) was used as the light source. All dispersions were 
passed through Millipore Millex-HV fi lters with a pore size of 0.80  μ m to 
remove dust before the DLS measurements. 
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